Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Clinical Study of DC-AML Cells in the Treatment of Acute Myeloid Leukemia — Stella

Home/Acute Myeloid Leukemia/Clinical Study of DC-AML Cells in the Treatment of Acute Myeloid Leukemia

View on ClinicalTrials.gov

Recruiting

Back to Acute Myeloid Leukemia trials

Clinical Study of DC-AML Cells in the Treatment of Acute Myeloid Leukemia

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

China

Department of hematology, Beijing, Beijing Municipality

Key details

Sponsor

Affiliated Hospital to Academy of Military Medical Sciences

Enrollment target

~20 participants

Started

July 2021

Primary completion

July 2026

Age range

18 Years – 70 Years

Last updated August 2021

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.